… EGFR mutations, and a trend toward improved overall survival [Citation8–Citation14]. As a
result, gefitinib, … with advanced NSCLCs with EGFR exon 19 deletions or the L858R mutation. …

… [23], [24], [25], [26], [27], [28], [29], [30] In this study, we explored the outcomes of some
relatively frequent single uncommon EGFR mutations, and differences in efficacy and prognosis …

… insights into the relative efficacy and toxicity of the EGFR-TKIs. … the efficacy and toxicity of
first-line treatment with gefitinib, … EGFR-mutated (exon 19 deletion or exon 21 L858R mutation) …

… EGFR mutations (actEGFRm) EGFR L858R and EGFR Del19 , in terms of safety, efficacy, and
… They yield promising efficacy in NSCLC patients with actEGFRm as well as EGFR T790M …

… and EGFR mutation-guided gefitinib gained lower QALYs at higher costs than the erlotinib
group. Comparing with EGFR mutation… , EGFR mutation-guided afatinib, erlotinib, gefitinib and …

… the clinical efficacy of gefitinib as monotherapy in … EGFR mutations.[37] Patients with Stage
IIIB or IV chemotherapy-naive NSCLC with EGFR mutation were treated with 250 mg gefitinib …

… acid-suppressing medication inhibits gefitinib absorption and … -line gefitinib for NSLC harboring
common EGFR mutation. … common sensitizing EGFR mutations who received gefitinib as …

… efficacy and safety of fruquintinib in combination with gefitinib, … EGFR-tyrosine kinase inhibitors
(TKIs) are the standard … patients with EGFR mutation-positive NSCLC; gefitinib, an EGFR-…

… -line treatment for NSCLC harboring EGFR mutations and suggested gefitinib plus pemetrexed-…
the efficacy and tolerability of adding pemetrexed-based chemotherapy to gefitinib as the …

… We aimed to compare the efficacy of adjuvant gefitinib versus vinorelbine plus cisplatin in …
We also did biochemical and haematological analyses and EGFR mutation testing, and we …